on 05 Jul 2022
Last Applicant/ Owned by
DK-2970 Hørsholm
DK
Serial Number
79312359 filed on 11th Feb 2021
Registration Number
6776851 registered on 05th Jul 2022
Correspondent Address
Mark Wright
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Reagents for immunoanalysis for medical use; preparations for pharmaceutical purposes; preparations for medical purposes; chemical-pharmaceutical preparations for pharmaceutical or medical purposes; diagnostic preparations for medical purposes, reagents for medical and veterinary purposes; vaccines; biochemical analysis preparations for medical purposes and the aforementioned preparations all for Read More
Reagents for scientific and research use, namely, reagents for immunoanalysis, not for medical use; chemical products for diagnostic, industrial and scientific purposes, namely, Diagnostic reagents and preparations, except for medical or veterinary use, Chemicals for use in industry and science, Chemical preparations for general industrial manufacturing; diagnostic reagents for scientific diagnostic not for medical and veterinary purposes; research reagents for scientific and diagnostic research purposes; diagnostic test materials for scientific and diagnostic purposes not for medical or veterinary purposes, namely, Diagnostic preparations, other than for medical or veterinary purposes, Diagnostic reagents for scientific or research use, Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; biochemical reagents used for non-medical purposes; chemical reagents, other than for medical or veterinary purposes; biochemical diagnostic kits for scientific and diagnostic purposes not for medical or veterinary purposes comprised of biochemical reagents used for non-medical purposes; biochemical analysis kits for research and diagnostic purposes not for medical and veterinary purposes comprised of biochemicals for in vitro and in vivo scientific use; biochemical analysis preparations for scientific purposes related to vaccines and immunotherapy, including cancer therapy, cancer immunotherapy, analysis or treatment of cancer, infectious diseases and/or autoimmunity, and for use in connection with toxicological studies, transplantation, and immune monitoring and T cell monitoring
Reagents for immunoanalysis for medical use; preparations for pharmaceutical purposes; preparations for medical purposes; chemical-pharmaceutical preparations for pharmaceutical or medical purposes; diagnostic preparations for medical purposes, reagents for medical and veterinary purposes; vaccines; biochemical analysis preparations for medical purposes and the aforementioned preparations all for development and analysis of vaccines, immunotherapy and cellular therapy, namely, cancer vaccines and cancer immunotherapy, and T cell therapies; biochemical analysis preparations for pharmaceutical or medical purposes for use in cancer therapy or other therapy, for the analysis of T cell infiltration of solid tumors and tissue, as well as infectious diseases, and for use in connection with toxicological studies, transplantation, immune monitoring, or vaccines and T cell monitoring, all for medical or veterinary purposes
Scientific and technological analyses of T cells and their responses, namely, research services and design of T cells and their responses; industrial analysis of T cells and their responses, including for development of medicines and vaccines; basic scientific and clinical research on T cells and their responses, including for the development of medicines and vaccines
No 79312359
No Service Mark
No 122591
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 05th Jul 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 05th Jul 2022 | REGISTERED-PRINCIPAL REGISTER |
| 03rd May 2022 | NOTIFICATION PROCESSED BY IB |
| 19th Apr 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 19th Apr 2022 | PUBLISHED FOR OPPOSITION |
| 13th Apr 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 13th Apr 2022 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| 30th Mar 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 14th Mar 2022 | ASSIGNED TO LIE |
| 11th Mar 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
